Correlation Between Crinetics Pharmaceuticals and Intellia Therapeutics
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Intellia Therapeutics, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Intellia Therapeutics.
Diversification Opportunities for Crinetics Pharmaceuticals and Intellia Therapeutics
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Crinetics and Intellia is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Intellia Therapeutics go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Intellia Therapeutics
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.65 times more return on investment than Intellia Therapeutics. However, Crinetics Pharmaceuticals is 1.53 times less risky than Intellia Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Intellia Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 4,686 in Crinetics Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 1,017 from holding Crinetics Pharmaceuticals or generate 21.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crinetics Pharmaceuticals vs. Intellia Therapeutics
Performance |
| Timeline |
| Crinetics Pharmaceuticals |
| Intellia Therapeutics |
Crinetics Pharmaceuticals and Intellia Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crinetics Pharmaceuticals and Intellia Therapeutics
The main advantage of trading using opposite Crinetics Pharmaceuticals and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.The idea behind Crinetics Pharmaceuticals and Intellia Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Transaction History View history of all your transactions and understand their impact on performance |